PTAB rejects Guardant Health's challenge to TwinStrand's duplex sequencing patent

TwinStrand Biosciences announced the U.S. Patent and Trademark Office's Patent Trial and Appeal Board rejected Guardant Health's challenge to a core patent underlying duplex sequencing.

Detected & updated continuously · Source: Nebula